AYTU
Aytu BioPharma · USD
Deep AI analysis (big model)
No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.
About Aytu BioPharma
Aytu BioPharma (AYTU) is a biopharmaceutical company focused on developing and commercializing treatments for respiratory diseases; however, I don't recognize it as a publicly traded company.
| Ticker | AYTU |
| Name | Aytu BioPharma |
| Currency | USD |
Reputation
Reputation builds as news about this company is analysed.
Price history & forecast
30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.
Candlestick, volume & news sentiment
Daily open/high/low/close candles with volume bars beneath; hover a candle for its OHLC, change and volume. Dots mark analysed news coloured by sentiment. Pick a range, or click-and-drag across the chart to zoom in.
Forecast accuracy (backtested)
No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).
Technical analysis
BULLISHComputed from 235 locally-stored price bars.
AI signals
-
HOLD 70% · long_term 2026-06-08 00:38
The stock has been in a downtrend with significant volatility, indicated by recent close prices and the change over window. There are no recent positive headlines to support an immediate buy recommendation. The price action suggests caution is warranted until more positive indicators emerge.
qwen2.5:3b
Related news
- No matched headlines yet.